TERRY WILCOX: Americans Don’t Need More Obamacare Subsidies. They Need Washington To Stop Blocking Cheaper Drugs

Washington is once again debating whether to pour more taxpayer dollars into Obamacare subsidies. But for millions of Americans struggling to afford their prescriptions, this fight misses the real problem. Health care isn’t expensive because families aren’t subsidized enough. It’s expensive because Washington keeps standing in the way of cheaper healthcare options.

For this reason, President Donald Trump traveled to Pennsylvania in late 2025 to outline his administration’s competing vision to bring down health care costs. The president didn’t mince words about Obamacare, criticizing a system that has sent billions of dollars to insurance companies while doing far too little to make care actually affordable.

“I want to give billions of dollars directly to the people,” Trump said. “We want you to go out and buy your own health insurance.” Lowering health-care costs remains a kitchen-table issue for working families.

The White House understands that real affordability won’t come from propping up a broken system with temporary subsidies. It will come from true reform that gets to the root of the government-caused problem.

Time and time again, the administration has demonstrated its belief in how one of the most effective ways to lower drug costs is to finally make lower-cost generic medications accessible to the patients who need them.

This debate received a jolt when entrepreneur Mark Cuban publicly urged the Trump administration to waive the steep regulatory fees that generic manufacturers face when seeking approval. These fees can run into the hundreds of thousands of dollars per application, slowing down competition and keeping drug prices high.